National Signing Day 2022
Story Poster
Recapping National Signing Day 2022 from Around the SEC and Texas
2 yr ago by Jason Howell
Jimbo Fisher and the Texas A&M football program signed the highest-rated recruiting class of all time as National Signing Day 2022 comes to a close. Jason Howell provides a recap of all the news surrounding this year's signees from around the country.
Story Poster
25:11
The Loochador Podcast: A&M wraps up No. 1 class of all-time on NSD22
2 yr ago by Billy Liucci
Texas A&M capped off the highest-ranked recruiting class of ALL-TIME by adding Shemar Stewart and Jacoby Mathews on National Signing Day. Billy Liucci and David Nuño react to the Aggies' signing day haul, Jimbo Fisher's rant and much, much more.
Story Poster
Beaming to Steaming: Jimbo Fisher lashes back at NIL rumors
2 yr ago by Olin Buchanan
On Wednesday, Jimbo Fisher and the Aggies put the finishing touches on the highest-rated recruiting class in the history of modern recruiting, but at a press conference, the Texas A&M coach took the opportunity to fight back against rumors the class was bought rather than built.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
'Expect not to sit': Shemar Stewart headed to Aggieland to make plays
2 yr ago by Jason Howell
Five-star defensive end Shemar Stewart put pen to the paper on Wednesday and signed with Texas A&M. By being the latest addition to the Aggies' No. 1-ranked class, Stewart is ready to get to College Station and work towards winning a national championship.
Story Poster
13:10
'It's unbelievable': Leone details Texas A&M's new offensive weapons
2 yr ago by David Nuño
Texas A&M is beginning to assemble a wealth of offensive talent that has never been seen before in College Station. Former Aggie running back Brandon Leone joined on National Signing Day to analyze the explosive weapons Jimbo Fisher has signed in 2022.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.